Literature DB >> 9473245

Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes.

M Pouliot1, M J James, S R McColl, P H Naccache, L G Cleland.   

Abstract

The formation and deposition of monosodium urate (MSU) microcrystals in articular and periarticular tissues is the causative agent of acute or chronic inflammatory responses known as gouty arthritis. Mononuclear phagocyte activation is involved in early triggering events of gout attacks. Because stimulated mononuclear phagocytes can constitute an important source of the inducible isoform of cyclooxygenase (COX-2), we evaluated the effects that proinflammatory microcrystals might have on COX-2 protein expression in crystal-stimulated monocytes. We found that MSU crystals, but not calcium pyrophosphate dihydrate (CPPD) crystals, induced COX-2, which correlated with the synthesis of prostaglandin E2 (PGE2) and thromboxane A2 (TXA2). Crystal-induced de novo synthesis of COX-2 was dependent on transcriptional and translational events. Inhibition of tyrosine phosphorylation, by herbimycin A, blocked crystal-induced COX-2. Similarly, an inhibitor of the p38 mitogen-activated protein kinase, SB 203580, inhibited the stimulation of COX-2. Colchicine inhibited crystal-induced COX-2. In all cases, prostanoid synthesis was concomitantly inhibited. Taken together, these results implicate COX-2 in the development of MSU-induced inflammation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473245

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  Treating acute gouty arthritis with selective COX 2 inhibitors.

Authors:  Adel G Fam
Journal:  BMJ       Date:  2002-11-02

2.  Role of the leucine-rich repeat domain of cryopyrin/NALP3 in monosodium urate crystal-induced inflammation in mice.

Authors:  Hal M Hoffman; Peter Scott; James L Mueller; Amir Misaghi; Sean Stevens; George D Yancopoulos; Andrew Murphy; David M Valenzuela; Ru Liu-Bryan
Journal:  Arthritis Rheum       Date:  2010-07

Review 3.  Uric acid as a danger signal in gout and its comorbidities.

Authors:  Kenneth L Rock; Hiroshi Kataoka; Jiann-Jyh Lai
Journal:  Nat Rev Rheumatol       Date:  2012-09-04       Impact factor: 20.543

4.  A customized Raman system for point-of-care detection of arthropathic crystals in the synovial fluid.

Authors:  Bolan Li; Shan Yang; Ozan Akkus
Journal:  Analyst       Date:  2014-02-21       Impact factor: 4.616

Review 5.  Molecular basis of oxidative stress in gouty arthropathy.

Authors:  Yessica Zamudio-Cuevas; Cristina Hernández-Díaz; Carlos Pineda; Anthony M Reginato; Jorge Francisco Cerna-Cortés; Lucio Ventura-Ríos; Alberto López-Reyes
Journal:  Clin Rheumatol       Date:  2015-04-09       Impact factor: 2.980

6.  Laser Wavelength Dependence of Background Fluorescence in Raman Spectroscopic Analysis of Synovial Fluid from Symptomatic Joints.

Authors:  Shan Yang; Bolan Li; Mikhail N Slipchenko; Anna Akkus; Nora G Singer; Yener N Yeni; Ozan Akkus
Journal:  J Raman Spectrosc       Date:  2013-08-01       Impact factor: 3.133

7.  Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes.

Authors:  Rong Yang; Nan Chiang; Sungwhan F Oh; Charles N Serhan
Journal:  Curr Protoc Immunol       Date:  2011-11

Review 8.  Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.

Authors:  Bruce N Cronstein; Prashanth Sunkureddi
Journal:  J Clin Rheumatol       Date:  2013-01       Impact factor: 3.517

9.  Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis.

Authors:  H Ralph Schumacher; Judith A Boice; David I Daikh; Saurabh Mukhopadhyay; Kerstin Malmstrom; Jennifer Ng; Guillermo A Tate; Javier Molina
Journal:  BMJ       Date:  2002-06-22

Review 10.  Hyperuricemia and gout.

Authors:  Frédéric Lioté
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.